ArticleEnvironmental health and preventive medicine2026
High serum PFAS levels in a population after exposure through drinking water in western Tokyo, Japan and their half-lives estimation.
Article in Environmental health and preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPer- and polyfluoroalkyl substances (PFAS) have raised significant health concerns. In 2019, drinking water source was changed due to PFAS contamination in the Tama region, Tokyo, Japan. This study aims to determine the PFAS exposure levels after reduction in drinking water contamination, and to estimate the half-lives of linear isomers of perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS), and perfluorooctanoic acid (PFOA) in serum samples from residents.
methods17 participants in 2020 and 2023 from Tama region, Tokyo, Japan (all females, age 53-83 years) were examined. PFAS concentrations in serum in 2023 were measured using gas chromatography-mass spectrometry. Biological half-lives were estimated using first-order kinetics model.
resultsThe investigated population was exposed to six PFAS at levels associated with potential health risks, with 95% of them having total PFAS concentrations exceeding 20 ng/mL in 2023. Serum PFOS, PFHxS and PFOA levels decreased from 2000 to 2023 (p < 0.05 by paired t-test). The estimated half-lives for PFOS, PFHxS, and PFOA were 3.9 years (95% CI: 3.4-4.6), 5.7 years (95% CI: 4.6-7.5), and 8.0 years (95% CI: 6.0-10.0), respectively. After subtraction of background values in Japan, the estimated half-lives were 2.7 years (95% CI: 2.3-3.4) for PFOS, 5.6 years (95% CI: 4.5-7.4) for PFHxS, and 5.1 years (95% CI: 4.1-6.8) for PFOA.
conclusionsThis study demonstrates participants had still higher serum PFAS levels and these PFAS elimination half-lives in the investigated Japanese population are at years order.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.